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Abstract
Scale invariance is a feature of complex biological systems, and abnormality of multi-scale behaviour may serve as an
indicator of pathology. The hypothalamic suprachiasmatic nucleus (SCN) is a major node in central neural networks
responsible for regulating multi-scale behaviour in measures of human locomotor activity. SCN also is implicated in the
pathophysiology of bipolar disorder (BD) or manic-depressive illness, a severe, episodic disorder of mood, cognition and
behaviour. Here, we investigated scaling behaviour in actigraphically recorded human motility data for potential indicators
of BD, particularly its manic phase. A proposed index of scaling behaviour (Vulnerability Index [VI]) derived from such data
distinguished between: [i] healthy subjects at high versus low risk of mood disorders; [ii] currently clinically stable BD
patients versus matched controls; and [iii] among clinical states in BD patients.
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Introduction
Scale invariance is a feature of biological complexity arising from
interactions of various physiological control nodes operating at
multiple time scales [1]. Loss of scale invariance can indicate
pathophysiological states as it represents a shift to fewer control
nodes [2]. In humans, the hypothalamic suprachiasmatic nucleus
(SCN) is a major node in neural networks responsible for multi-
scale regulation of biological rhythms. In particular, the SCN is
responsible for scale-invariant properties of temporal fluctuations
in locomotor activity [3]. Multi-scale properties of activity data can
be important clinically, and are readily detected non-invasively
and recorded by wrist-worn, microprocessor-controlled, piezoelec-
tric actigraphic devices. Multi-scale features of physiological data
have proved useful in understanding various clinical states as
diverse as heart disease [4,5], asthma [6], schizophrenia [7], and
clinical depression [7,8,9].
Bipolar (manic-depressive) disorder (BD) is a relapsing, major
psychiatric disorder with poorly understood neurobiology, typi-
cally incomplete treatment responses, and often unsatisfactory
clinical outcomes, with a high risk of premature mortality due to
suicide and other causes. BD may be particularly well suited to the
investigation of multi-scale properties of motility data. Its complex
manifestations include marked disturbances of locomotor activity
[10,11] as well as major changes in mood, thinking, and many
aspects of behavior. Furthermore, the SCN may be involved in the
regulation of behavior and mood in BD patients [12]. Develop-
ment of non-invasive, objective correlates or predictors of morbid
states in BD patients may support more timely and efficient clinical
interventions aimed at limiting risk of recurrence of major episodes
of illness.
Based on this background, we sought biologically plausible
correlates of BD in multi-scale characteristics of daily motility
rhythms in human subjects, including patients with reliably
diagnosed BD in a range of ill and remitted clinical states, healthy
controls, and subjects showing a range of potential vulnerabilities
for BD based on standardized and validated behavioural and
symptomatic ratings. We hypothesized that multi-scale behavior in
motility rhythms recorded over several days would: [1] distinguish
between high and low vulnerability to BD in apparently healthy
young adults, [2] distinguish BD patients from healthy, sex- and
age-matched controls, and [3] distinguish among different
psychopathological states of BD patients.
We tested these hypotheses using data collected with wrist-
worn actigraphs in three experimental protocols. Study 1
involved healthy young adults with no history of mental illness,
in Melbourne, Australia. Their potential risk of future BD was
assessed using the well-validated General Behavior Inventory
(GBI) [13,14]. We divided subjects by highest versus lowest
deciles of resulting GBI scores into those with apparently low risk
(n=35; 77.1% women; mean6SD, age =20.962.3) versus high
risk for BD (n=35; 65.7% women; age 22.363.0 years). Subjects
wore an actigraph continuously on the nondominant wrist for
seven days. For Study 2, in Australia, we recruited currently
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by DSM-IV criteria (n=15; 46.7% women; age 46.8612.4) and
healthy controls with no history or current clinical evidence of
mental illness, low GBI scores, and matched approximately for
sex and age (n=15; 46.7% women; age =46.7614.1), who also
wore an actigraph for seven days. In Study 3, at the University
of Parma, Italy, patients with a DSM-IV diagnosis of type-I BD
(n=51; 70.6% women; age 43.8610.5 years) were actigraphically
monitored prospectively for 3 days during acute manic (n=21)or
mixed manic-depressive states (n=13), episodes of major
depression (n=13), and during full clinical recovery (n=46)
sustained for at least 60 days (total of 90 observations).
Measures of output variables representing underlying dynamics
of a biological system can exhibit complex fluctuations across
different time scales. Based on nonlinear system theory, the multi-
scale features of these measures can be characterized [4,5,15].
The past decade has seen growing interest in nonlinear
dynamical analysis of physiological data [16,17], and a range of
computational approaches have been used to seek hidden signals
of pathology from the measures of the time series [18,19,20]. In
the present study, we focused on amplitude behavior since
amplitude of motility data is physiologically grounded as a
measure of strength of physiological oscillations regulated by the
SCN [21,22].
Results
Probability distribution of multi-scale amplitudes
To understand the multi-scale characteristics of amplitude
measures of motility data collected with actigraphy, we considered
data from Study 1. A wavelet transform[23] (see Methods) was used
to extract amplitude of motility rhythms at different time scales
ranging from 0.2 to 26 h. Motility data are highly non-stationary
due to various extrinsic and intrinsic factors [24], and wavelet
transform is a powerful method for obtaining amplitude at multiple
time scales from such non-stationary biological signals [15].
Rhythms were observed at circadian (,24 h) as well as other
temporal ranges (minutes or hours). Figure 1 represents an
example of motility data along with the multi-scale rhythms
obtained using wavelet analysis. The amplitude of rhythms at
shorter time scales appeared to be random; to check whether such
fluctuation was simply due to noise in the data, we plotted the
distribution of amplitudes at a range of time-scales. The
distribution of amplitudes obtained at very short time-scales
(#2.0 h) had an apparent long-tail and was nearly collapsed
(Figure 2 (a–d)). Such a long-tail distribution is characteristic of
nonlinear complex systems near critical points, and the collapse of
amplitude distribution represents the scale-invariant feature of
such systems [25].
Figure 1. Estimated multi-scale rhythms of motility data obtained by wavelet analysis. (a) Raw data in arbitrary units (a.u) along with the
rhythms detected at three different time scales. (b) The detected rhythm (grey line) along with its amplitude (blue line) for a scale of 0.2 h. (c) The
corresponding rhythm and amplitude for a scale of 1.04 h. (d) The same measure at a scale of 23.48 h. Wavelet amplitudes are in normalized arbitrary
units.
doi:10.1371/journal.pone.0020650.g001
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intrinsic nonlinear property of the motility data rather than an
artifact of wavelet analysis, we performed surrogate data analysis,
a standard test to confirm nonlinearity of the data [26]. Surrogate
data were obtained by Fourier transform of the original motility
data, preserving the amplitude, randomizing the phases, and then
computing inverse Fourier transforms. Since both amplitude and
the power spectrum were preserved in the surrogate data, it might
be expected that the amplitude distribution for the surrogate and
original data would be identical.
However, wavelet analysis indicated that the amplitude
distribution for the surrogate data followed a Gaussian distribution
without a long tail. In addition, we generated artificial data with
values obtained from a Gaussian distribution, and repeated the
wavelet analysis. The amplitude distribution of such artificial data
at lower time scales had a similar distribution to that of the
surrogate data (Figure 2 (e–f)). These observations imply the
presence of nonlinear interactions in the original motility data and
that the long-tail distribution of amplitude was an intrinsic
property.
Derivation of Vulnerability Index (VI) of BD
To characterize the long-tail distribution, we sought the
distribution function that best fit the observed amplitude
distribution. Although Gamma functions are considered optimal
for characterizing such long-tail distributions [27], we compared
the goodness-of-fit of the amplitude distribution for both Gamma
and Rayleigh [28] distributions. Theoretically, based on the
central limit theorem, amplitude at different time-scales for data
derived from a Gaussian distribution should follow a Rayleigh
distribution, whereas a long-tail distribution characterized by a
Gamma distribution should reveal the presence of nonlinear
interactions [15]. We found that for scales up to 2.0 h, the fit of the
Gamma distribution was better than the Rayleigh distribution
based on Akaike Information Criteria (AIC) [29].
To look for any scale-invariant feature in the amplitude
distribution at multiple time scales, we plotted the estimated
shape parameter, c, of the Gamma distribution fit at different time
scales. We found that the shape parameter exhibited multi-scale
behavior (Figure 3). If the shape parameter of the individual
distribution showed a constant value for time scales up to 2.0 h,
this would indicate scale-invariance. However, the shape param-
eter decreased at short time scales and gradually increased at
longer time scales. Although the long-tail distribution was a
property of the data, the amplitude distribution lacked a scale-
invariant feature. Since such a non-collapsed nature of the
distribution may represent an abnormality of the system, we
investigated plausible correlates of this multi-scale behavior to the
illness of BD. To quantify the observed behavior, we integrated the
shape parameter up to 2.0 h time scales for each subject as Ð 2
0:2 c s ðÞ ds. The derived integral, termed a vulnerability index (VI),
was used in hypothesis-testing analyses.
VI as a marker for detecting trait of BD
Hypothesis 1 was tested with data from Study 1, in which the
low risk group, based on lowest decile GBI ratings, had 12% lower
mean VI scores (2.1160.45) than the high risk group (2.3960.42).
Logistic regression modeling indicated that VI was significantly
associated with presumptive high risk for BD (F [df=1; 66]=8.69,
p=0.004), but that sex and age were not. Similarly, testing of
Figure 2. Probability distribution P(A) of amplitude, A, obtained by wavelet analysis of motility data. (a) Rescaled distributions,
normalized to provide unit area by rescaling using Pmax, of amplitude at a range of time-scales up to 2 h from a subject considered to be at low risk
for BD by GBI criteria. (b) The same data, log-transformed and showing a long-tail, which share most of the values of log (APmax). (c) Amplitude
distribution at a specific scale (s=0.54 h) for 35 subjects considered to be at low risk for BD by GBI criteria. (d) The same for 35 other subjects at high
risk for BD. (e) Amplitude distribution up to 2 h for a subject at high risk for BD (blue line) and the corresponding surrogate data (red line); the
amplitude distribution (black line) obtained from the wavelet analysis of data derived from a Gaussian distribution follows the amplitude distribution
of surrogate data. (f) Log-transformed amplitude from panel e; here, wavelet amplitudes of Gaussian as well as surrogate data have identical
distributions without a long-tail, and differ from the distribution of the original data.
doi:10.1371/journal.pone.0020650.g002
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among patients diagnosed with BD (2.5360.49) than in healthy
control subjects (2.1760.40), and that VI score was associated with
the diagnosis of BD, based on logistic regression modelling
(F[df=1;26]=4.65, p=0.04).
When all subjects from Studies 1 and 2 were included in a
multivariate linear regression modelling, with GBI score as the
dependent measure, and controlling for sex and age, the VI score
was significantly and independently associated with either high risk
for, or diagnosis of BD, and was the only factor associated (F
[df=3; 96]=4.94, p=0.001). Likewise, we found a significant
linear trend in the mean magnitude of VI measures, ranking: low-
GBI score , healthy controls # non-BD patients with high GBI
scores , BD patients (Figure 4), with control for sex and age (F
[df=3; 94]=4.28, p=0.007, b=0.32, p=0.01).
These findings indicate the presence of a consistent and
significant association between VI scores and GBI scores as an
indication of trait for BD in healthy subjects with high versus low
GBI scores, and in comparison of BD patients with sex- and age-
matched healthy controls.
Circadian amplitude and detrended fluctuation measure
of motility data
To check whether vulnerability to BD would typically be
inferred from more common analyses of ,24-hour (circadian)
features of actigraphic data, we estimated the predominant
component using wavelet transform along with a ridge extraction
algorithm [30]. Figure 5 represents an example of the estimated
predominant amplitude and the period from a representative
human subject. The predominant component of motility data was
in the circadian range. However the predominant amplitude in
arbitrary units (mean 6 SD ranked for low risk: 4466150, versus
high risk: 4116145 subjects, BD patients: 3326132, versus healthy
controls: 4356146) and the predominant period in hours (mean 6
SD ranked for low risk subjects: 24.060.20, high risk subjects:
23.960.3, BD patients: 24.060.05, healthy controls: 24.060.1) of
the circadian component did not show significant differences
among the subject-groups.
Detrended fluctuation analysis has indicated that motility data
have long range correlations with a scale-invariant feature in
temporal fluctuations ranging up to 24 h, and that these
Figure 3. Characterization of the probability distribution of amplitudes using Gamma and Rayleigh functions. (a) Probability
distribution P(A) for a subject considered to be a low risk for BD at a scale s,0.59 h, along with Gamma (black line) and Rayleigh (grey line) best-fit
functions: based on AIC, the Gamma distribution yields a better fit. (b) Probability distribution P(A) at a scale of s,3.0 h for the same subject: the fit of
the Rayleigh distribution function (gray line) is superior to the Gamma function at this scale, by AIC criteria. (c) Average value of the shape parameter,
c, at different scales (hours) for 35 subjects considered to be low risk for BD by GBI criteria (open circles) and another 35 at high risk (filled circles).
doi:10.1371/journal.pone.0020650.g003
Figure 4. Estimated means (±SEM) computed vulnerability index (VI) values in four groups of human subjects of increasing risk or
presence of BD. Low risk by GBI criteria (n=35), healthy controls (n=15), high-risk by GBI criteria (n=35), and patients diagnosed with DSM-IV type-
I BD who are currently clinically stable or euthymic (n=15). Curve-fitting found that mean VI increased linearly across these groups (F [df=3;
94]=4.28, p=0.007, controlling for sex and age).
doi:10.1371/journal.pone.0020650.g004
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Alzheimer’s disease from healthy elderly controls[31]. By applica-
tion of detrended fluctuation analysis [31] of the present motility
data, we considered whether such fluctuations were different
among the various groups of test subjects. Although we found a
scale-invariant feature in temporal fluctuations, its characterizing
parameter, scaling exponent, (mean 6 SD) did not differ
significantly among subject-groups. This measure ranked: low risk
subjects, 0.9860.07=high risk subjects, 0.9860.06. healthy
controls, 0.9660.05. BD patients, 0.9460.09.
VI as a marker for detecting different morbid phases of
BD
We used data from Study 3 to test whether differences in VI
values were associated with varying clinical states of BD
(Hypothesis 3). Statistical findings are shown based on linear
correlations (Table 1), which were supported by nonparametric
Spearman rank-correlations (not shown). Regression modelling,
with control for sex and age indicated that VI was significantly and
uniquely associated with both self- (b=0.31, t=2.76) and
clinician-rated mania (b=0.33, t =3.07, both p=0.01), whereas
age was a lesser covariate (b=0.239, p=0.05). The pattern of
findings was replicated with multi-level modelling to account for
nesting of assessments within subjects: and a significant relation-
ship was found between VI and both self- (t [df=78]=2.97,
p=0.004) and clinician-rated mania (t [df=81]=2.54, p=0.013).
Importantly, regression analyses found no correlation of VI with
depressive symptom ratings (Hamilton Depression Rating Scale
[HDRS] score or self-rated depression F [df=3;79]=2.32, and F
[df=3;76]=1.21 both p.0.05). However, there was a significant
increase in mean VI values across mood-states, ranking: major
depression , minor depression , euthymia , minor mixed-states
, hypomania , major mixed-states , mania (Figure 6).
Discussion
We identified a novel scaling behaviour of the amplitude
measures of locomotor activity in human subjects. Importantly, an
index of this multi-scale behaviour, the ‘‘vulnerability index’’ (VI),
is found to be clinically meaningful. That is, higher VI scores were
found in subjects with apparently high versus low vulnerability to
BD (high versus low GBI scores), and in BD patients versus
healthy, matched controls. We propose that an elevated value of
VI can serve as a novel and effective indicator of trait for BD as
well as being characteristic of subjects with clinically diagnosed
BD. In these subject-groups vulnerability for BD manifested in the
amplitude characteristics of activity data at lower time scales,
which appeared as noise to the naked eye, and were unrelated to
the temporal long-range correlations or typically-analysed circa-
dian features of motility rhythms.
The VI is specifically sensitive to mania and manic symptoms,
which distinguish BD from other mood disorders. However, VI is
insensitive to depression, consistent with the view that mania and
depression in BD have dissimilar pathophysiologies [32]. Further-
more, the increasing variations of VI across different mood states,
as shown in Figure 6, suggest that the VI might be a specific and
sensitive indicator of a gradually emerging component of
psychomotor activation from predominantly inhibited or psycho-
motorically retarded depressive states towards mixed or manic
states.
Figure 5. Estimated predominant component of motility data. (a) The raw data in arbitrary units (a.u). (b) The estimated circadian rhythm
(black line) with its amplitude (blue line). (c) The estimated circadian period (red line) in hours. Due to the non-stationary nature of the data, the
estimated amplitude and the period show cycle-to-cycle variability. (d) Normalized scalogram at a specific time of 32 hr. The peak power occurred at
a period of 23 h
doi:10.1371/journal.pone.0020650.g005
Table 1. Correlations of individual values of vulnerability
index (VI) with self- and clinician-ratings of manic and
depressive symptom-severity.
Correlate r-value p-value
Manic Symptoms
Clinician-rated with YMRS +0.304 0.005
Self-rated +0.305 0.006
Depressive Symptoms
Clinician-rated with HDRS) 20.017 0.877
Self-rated) 20.114 0.313
doi:10.1371/journal.pone.0020650.t001
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the pathophysiology of BD [33]. Of various SCN-related rhythms,
human motility can easily be monitored noninvasively and
inexpensively, either intermittently for short times, or continuously
for long periods under naturalistic conditions, making it
particularly well-suited to longitudinal tracking of illness-course
and treatment responses in BD patients. Further research is
warranted to investigate the biological substrate of VI and to
confirm its potential utility as an objective marker of risk for, or
presence of BD, and of its selectivity for manic versus depressive
features. It might also bear testing as early indicator of impending
clinical relapse into manic or mixed states of BD arising from
depression or euthymia.
Methods
Ethics Statement
All subjects provided written informed consent for aggregate
and anonymous reporting of data arising from their clinical and
actigraphic assessments. Study 1 was approved by Swinburne
University Human Research Ethics Committee; Study 2 was
approved by Bendigo Health Care Group Ethics Committee and
Study 3 was approved by the Ethics Committee of the University
of Parma Medical Center, in full accordance with international
standards for the ethical use of human subjects in research.
Psychiatric measures
The 73-item GBI is a reliable and validated self-report measure
with stable between-subject differences that are reported to reflect
vulnerability to BD. [34,35]. In Study 3, clinician ratings of
symptom-status were made with the Young Mania Rating Scale
(YMRS) [36] and the Hamilton Rating Scale for Depression
(HDRS) [37]. Subjects in Study 3 also self-rated symptoms on a
series of 10-cm visual analog scales (29 items) based on items of the
YMRS and HDRS as well as the Bonn Scale for the Assessment of
Basic Symptoms (BSABS) [38].
Subjects
Study 1. Exclusion criteria included past history of mania/
hypomania, working shift work, or having a physical condition
that would confound activity measurement. The highest versus
lowest deciles of the distribution of GBI scores, identified 35
subjects considered to be at high-risk, and 35 at low-risk for BD
from an initial sample of 358. Mean GBI score differed by more
than ten-fold between subjects with low versus high apparent risk
for BD (10.566.20 vs. 109626.3, F [df=1; 68])=465, p,0.001).
Study 2: Clinical subjects were recruited from an outpatient
public mental health service in Victoria, Australia, who met DSM-
IV criteria for a diagnosis of type-I BD as determined by an
experienced research psychiatrist. Sex- and age-matched healthy
controls were recruited through network of researchers. Study 3:
Patients were recruited as inpatients at the Section of Psychiatry of
the University of Parma, Italy, whose DSM-IV diagnosis of type I
BD was supported by semi-structured interviews by a research
psychiatrist over prolonged (7.4362.24 years) follow-up as
outpatients.
Activity measurement
Actigraphy is commonly used to document rest/activity cycles
under naturalistic conditions and to characterize abnormal sleep/
wake behaviour and altered circadian rhythms amongst ill or
euthymic BD patients. In the present studies, subjects wore an
actigraph continuously on the non-dominant wrist under natural-
istic conditions for 3–7 days. The Mini-Mitter ActiwatchH 64
(Respironics, Inc. Bend, OR, USA) was used in Studies 1 and 2,
and AMA-128K Mini-MotionloggerH Actigraph (Ambulatory
Monitoring, Inc. [AMI], Ardsley, NY, USA) in Study 3. Activity
data were obtained at 32 Hz and integrated at every 0.1 h.
Figure 6. Mean (±SEM) computed vulnerability index (VI) values associated with various mood states of patients meeting DSM-IV
diagnostic criteria for type-I BD. VI rises consistently and significantly with increasing manic features, from major depression, through mild
depression or dysthymia, subclinical or mild mixed manic-depression, hypomania, mixed major manic-depressive states, to current mania-all in BD
patients.
doi:10.1371/journal.pone.0020650.g006
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The continuous wavelet transform of digitally acquired motility
data, xn with n~1,2,......,N is obtained by the convolution of
the data with a scaled and translated version of a mother wavelet
[23], as:
Wn(s)~
XN{1
n’ xn’Y  n’{n ðÞ dt
s
  
ð1Þ
where dt=0.1 hr, N is the total number of data points, s is the
scale defined in a dyadic representation as sj~so20:5j with so~2dt
and 4 sub-octave per octave of the dyadic scale to obtain a total
number of 57 scales with j~0,1,......56. Y  represents the
complex conjugate of the normalized wavelet function, where:
Y
n’{n ðÞ dt
s
  
~
dt
s
   1=2
Yo
n’{n ðÞ dt
s
  
ð2Þ
We performed this convolution with a Morlet wavelet, a plane
wave modulated by a Gaussian function defined as
Yo ndt=s ðÞ ~p{0:25ei6ndt=se{0:5 ndt=s ðÞ 2
ð3Þ
Since the Morlet wavelet is a complex function, the obtained
wavelet transformation of the data, Wn s ðÞ , is also complex with a
real part and an imaginary part. Therefore, corresponding to each
scale the amplitude is defined as As ðÞ ~ Wn s ðÞ jj . The obtained
amplitudes are in normalized units.
To determine the predominant component of the motility data
we employed the wavelet transform with an increased resolution of
scale with 256 sub-octaves per octave in the dyadic representation.
At each time point, using a ridge extraction algorithm[30], the
scale at which the normalized scalogram has a peak value is
detected. The corresponding amplitude multiplied by the
appropriate de-noising factor [23] at this scale is the predominant
amplitude and the corresponding period is the predominant
period. Our approach for determining the predominant compo-
nent is similar to the method employed for estimating circadian
oscillations from bioluminescence data [39,40].
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